Stocks and Investing
Stocks and Investing
Thu, July 28, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Deepa Raghavan Maintained (TMHC) at Hold with Increased Target to $30 on, Jul 28th, 2022
Deepa Raghavan of Wells Fargo, Maintained "Taylor Morrison Home Corporation" (TMHC) at Hold with Increased Target from $25 to $30 on, Jul 28th, 2022.
Deepa has made no other calls on TMHC in the last 4 months.
There are 4 other peers that have a rating on TMHC. Out of the 4 peers that are also analyzing TMHC, 2 agree with Deepa's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Alex Rygiel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $28 on, Thursday, June 16th, 2022
- Matthew Bouley of "Barclays" Downgraded from Buy to Hold and Decreased Target to $33 on, Thursday, March 31st, 2022
These are the ratings of the 2 analyists that currently disagree with Deepa
- Michael Rehaut of "JP Morgan" Maintained at Buy with Decreased Target to $30 on, Tuesday, July 12th, 2022
- Daniel Oppenheim of "Credit Suisse" Upgraded from Hold to Buy and Held Target at $33 on, Monday, July 11th, 2022
Contributing Sources